Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines

Issued on behalf of Avaí Bio, Inc. USANewsGroup.com News Commentary VANCOUVER, BC, April 6, 2026 /PRNewswire/ -- The global cell therapy manufacturing market is on track to nearly double, from $7.17 billion in 2026 to over $14 billion by 2035[1]. The science has been proving itself for...